| 1 |
中国医疗保健国际交流促进会糖尿病足病分会.中国糖尿病足诊治指南[J].中华医学杂志, 2017, 97(4):251-258.
|
| 2 |
Bowling FL, Rashid ST, Boulton AJ. Preventing and treating foot complications associated with diabetes mellitus[J]. Nat Rev Endocrinol, 2015, 11(10):606-616.
|
| 3 |
Fei Y F, Wang C, Chen DW, et al. [Incidence and risk factors of amputation among inpatients with diabetic foot][J]. Zhonghua Yi Xue Za Zhi, 2012, 92(24):1686-1689.
|
| 4 |
Peter-Riesch B. The diabetic foot: the Never-Ending challenge[J]. Endocr Dev, 2016, 31:108-134.
|
| 5 |
Ahmed M, Reffat SA, Hassan A, et al. Platelet-Rich plasma for the treatment of clean diabetic foot ulcers[J]. Ann Vasc Surg, 2017, 38(1):206-211.
|
| 6 |
Liu J, Zhang P, Tian J, et al. Ozone therapy for treating foot ulcers in People with diabetes[J]. Cochrane Database of Systematic Reviews, 2015(10):D8474.
|
| 7 |
Marti-Carvajal AJ, Gluud C, Nicola SA, et al. Growth factors for treating diabetic foot ulcers[J]. Cochrane Database of Systematic Reviews, 2015 (10):D8548.
|
| 8 |
Lavery LA, Fulmer J, Shebetka KA, et al. The efficacy and safety of Grafix (R) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial[J]. Int Wound J, 2014, 11(5):554-560.
|
| 9 |
Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial[J]. Lancet, 2002, 360(9331):427-435.
|
| 10 |
Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes[J]. J Clin Invest, 2007, 117(5):1219-1222.
|
| 11 |
Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease-From marvel to menace[J]. Circulation, 2006, 113(13):1708-1714.
|
| 12 |
Sibbald RG, Woo KY. The biology of chronic foot ulcers in persons with diabetes[J]. Diabetes Metab Res Rev, 2008, 24(1):S25-S30.
|
| 13 |
Kalan L, Loesche M, Hodkinson BP, et al. Redefining the Chronic-Wound microbiome: fungal communities are prevalent, dynamic, and associated with delayed healing[J]. MBio, 2016, 7(5):e01016-e01058.
|
| 14 |
Kretzschmar K, Cottle DL, Donati G, et al. Blimp1 is required for postnatal epidermal homeostasis but does not define a sebaceous gland progenitor under steady-state conditions[J]. Stem Cell Reports, 2014, 3(4):620-633.
|
| 15 |
Wicks K, Torbica T, Mace KA. Myeloid cell dysfunction and the pathogenesis of the diabetic chronic wound[J]. Semin Immunol, 2014, 26(4):341-353.
|
| 16 |
Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells[J]. Science, 1999, 284(5411):143-147.
|
| 17 |
Cerqueira MT, Pirraco RP, Marques AP. Stem cells in skin wound healing: are we there yet?[J]. Advances in wound care, 2016, 5(4):164-175.
|
| 18 |
Qi Y, Jiang D, Sindrilaru A, et al. TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine Full-Thickness skin wounds[J]. J Invest Dermatol, 2014, 134(2):526-537.
|
| 19 |
Qin HL, Zhu XH, Zhang B, et al. Clinical evaluation of human umbilical cord mesenchymal stem cell transplantation after angioplasty for diabetic foot[J]. Exp Clin Endocrinol Diabetes, 2016, 124(8):497-503.
|
| 20 |
Wan JB, Xia LL, Liang WJ, et al. Transplantation of bone Marrow-Derived mesenchymal stem cells promotes delayed wound healing in diabetic rats[J]. J Diabetes Res, 2013 (2013):647107.
|
| 21 |
Kuo YR, Wang CT, Cheng JT, et al. Bone Marrow-Derived mesenchymal stem cells enhanced diabetic wound healing through recruitment of tissue regeneration in a rat model of Streptozotocin-Induced diabetes[J]. Plast Reconstr Surg, 2011, 128(4):872-880.
|
| 22 |
Falanga V, Iwamoto S, Chartier M, et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds[J]. Tissue Eng, 2007, 13(6):1299-1312.
|
| 23 |
Han SK, Yoon TH, Lee DG, et al. Potential of human bone marrow stromal cells to accelerate wound healingin vitro[J]. Ann Plast Surg, 2005, 55(4):414-419.
|
| 24 |
Kim CH, Lee JH, Won JH, et al. Mesenchymal stem cells improve wound healingin vivovia early activation of matrix metalloproteinase-9 and vascular endothelial growth factor[J]. J Korean Med Sci, 2011, 26(6):726-733.
|
| 25 |
Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views[J]. Stem Cells, 2007, 25(11):2896-2902.
|
| 26 |
Si Y, Zhao Y, Hao H, et al. Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity[J]. Diabetes, 2012, 61(6):1616-1625.
|
| 27 |
Dash NR, Dash SN, Routray PA, et al. Targeting nonhealing ulcers of lower extremity in human through autologous bone Marrow-Derived mesenchymal stem cells[J]. Rejuvenation Res, 2009, 12(5):359-366.
|
| 28 |
Makrantonaki E, Wlaschek M, Scharffetter-Kochanek K. Pathogenesis of wound healing disorders in the elderly[J].J Dtsch Dermatol Ges, 2017, 15(3):255-275.
|
| 29 |
刘璠，周慧敏，杨爱格,等.不同来源单个核细胞移植对2型糖尿病下肢血管病变的疗效比较[J].中华细胞与干细胞杂志(电子版), 2016, 6(6):351-355.
|
| 30 |
黄平平，李尚珠，韩明哲,等.自体外周血干细胞移植治疗下肢动脉硬化性闭塞症[J].中华血液学杂志, 2003, 24(6):308-311.
|
| 31 |
Peeters Weem SM, Teraa M, Den Ruijter HM, et al. Quality of Life after treatment with autologous bone marrow derived cells in no option severe limb ischemia[J]. Eur J Vasc Endovasc Surg, 2016, 51(1):83-89.
|
| 32 |
DubskýM, JirkovskáA, Bem R, et al. Comparison of the effect of stem cell therapy and percutaneous transluminal angioplasty on diabetic foot disease in patients with critical limb ischemia[J]. Cytotherapy, 2014, 16(12):1733-1738.
|
| 33 |
Dubsky M, Jirkovska A, Bem R, et al. Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment[J].Diabetes Metab Res Rev, 2013, 29(5):369-376.
|
| 34 |
Narazaki G, Uosaki H, Teranishi M, et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells[J]. Circulation, 2008, 118(5):498-506.
|
| 35 |
Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons[J]. Science, 2008, 321(5893):1218-1221.
|
| 36 |
Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells[J]. Nature, 2007, 448(7151):313-317.
|
| 37 |
Hanna J, Wernig M, Markoulaki S, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin[J]. Science, 2007, 318(5858):1920-1923.
|
| 38 |
Tateishi K, He J, Taranova O, et al. Generation of insulin-secreting islet-like clusters from human skin fibroblasts[J].J Biol Chem, 2008,283 (46):31601-31607
|
| 39 |
王荣.诱导多功能干细胞(iPS)对小鼠下肢缺血再灌注损伤的保护作用研究[D]. [宁夏]:宁夏医科大学, 2013 .
|
| 40 |
Tanaka R, Masuda H, Kato S, et al. Autologous G-CSF-Mobilized peripheral blood CD34(+) cell therapy for diabetic patients with chronic nonhealing ulcer[J]. Cell Transplant, 2014, 23(2):167-179.
|
| 41 |
Zannettino A, Paton S, Arthur A, et al. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo[J]. J Cell Physiol, 2008, 214(2):413-421.
|
| 42 |
Sumi M, Sata M, Toya N, et al. Transplantation of adipose stromal cells,but not mature adipocytes,augments ischemia-induced angiogenesis[J]. Life Sci, 2007, 80(6):559-565.
|
| 43 |
Sato H, Ebisawa K, Takanari K, et al. Skin-derived precursor cells promote wound healing in diabetic mice[J]. Ann Plast Surg, 2015, 74(1):114-120.
|